img

Global Hereditary Angioedema Therapeutic Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hereditary Angioedema Therapeutic Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
Hereditary Angioedema Therapeutic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hereditary Angioedema Therapeutic market is projected to reach US$ 3050.6 million in 2034, increasing from US$ 2088.6 million in 2022, with the CAGR of 5.1% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hereditary Angioedema Therapeutic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hereditary Angioedema Therapeutic key companies include BioCryst Pharma, Ionis Pharma, Pharming Group, CSL Limited, Shire, Attune Pharma, Adverum Biotechnologies and KalVista Pharma, etc. BioCryst Pharma, Ionis Pharma, Pharming Group are top 3 players and held % share in total in 2022.
Hereditary Angioedema Therapeutic can be divided into Intravenous, Subcutaneous and Oral,, etc. Intravenous is the mainstream product in the market, accounting for % share globally in 2022.
Hereditary Angioedema Therapeutic is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Hereditary Angioedema Therapeutic industry development. In 2022, global % share of Hereditary Angioedema Therapeutic went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hereditary Angioedema Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Segment by Type
Intravenous
Subcutaneous
Oral

Segment by Application


Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hereditary Angioedema Therapeutic market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Hereditary Angioedema Therapeutic introduction, etc. Hereditary Angioedema Therapeutic Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Hereditary Angioedema Therapeutic market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Hereditary Angioedema Therapeutic
1.1 Hereditary Angioedema Therapeutic Market Overview
1.1.1 Hereditary Angioedema Therapeutic Product Scope
1.1.2 Hereditary Angioedema Therapeutic Market Status and Outlook
1.2 Global Hereditary Angioedema Therapeutic Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Hereditary Angioedema Therapeutic Market Size by Region (2024-2034)
1.4 Global Hereditary Angioedema Therapeutic Historic Market Size by Region (2024-2024)
1.5 Global Hereditary Angioedema Therapeutic Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Hereditary Angioedema Therapeutic Market Size (2024-2034)
1.6.1 North America Hereditary Angioedema Therapeutic Market Size (2024-2034)
1.6.2 Europe Hereditary Angioedema Therapeutic Market Size (2024-2034)
1.6.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size (2024-2034)
1.6.4 Latin America Hereditary Angioedema Therapeutic Market Size (2024-2034)
1.6.5 Middle East & Africa Hereditary Angioedema Therapeutic Market Size (2024-2034)
2 Hereditary Angioedema Therapeutic Market by Type
2.1 Introduction
2.1.1 Intravenous
2.1.2 Subcutaneous
2.1.3 Oral
2.2 Global Hereditary Angioedema Therapeutic Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Type (2024-2024)
2.2.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Hereditary Angioedema Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Hereditary Angioedema Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Hereditary Angioedema Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Hereditary Angioedema Therapeutic Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Hereditary Angioedema Therapeutic Revenue Breakdown by Type (2024-2034)
3 Hereditary Angioedema Therapeutic Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Hereditary Angioedema Therapeutic Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Application (2024-2024)
3.2.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Hereditary Angioedema Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Hereditary Angioedema Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Hereditary Angioedema Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Hereditary Angioedema Therapeutic Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Hereditary Angioedema Therapeutic Revenue Breakdown by Application (2024-2034)
4 Hereditary Angioedema Therapeutic Competition Analysis by Players
4.1 Global Hereditary Angioedema Therapeutic Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2022)
4.3 Date of Key Players Enter into Hereditary Angioedema Therapeutic Market
4.4 Global Top Players Hereditary Angioedema Therapeutic Headquarters and Area Served
4.5 Key Players Hereditary Angioedema Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Hereditary Angioedema Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioCryst Pharma
5.1.1 BioCryst Pharma Profile
5.1.2 BioCryst Pharma Main Business
5.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
5.1.4 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.1.5 BioCryst Pharma Recent Developments
5.2 Ionis Pharma
5.2.1 Ionis Pharma Profile
5.2.2 Ionis Pharma Main Business
5.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
5.2.4 Ionis Pharma Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.2.5 Ionis Pharma Recent Developments
5.3 Pharming Group
5.3.1 Pharming Group Profile
5.3.2 Pharming Group Main Business
5.3.3 Pharming Group Hereditary Angioedema Therapeutic Products, Services and Solutions
5.3.4 Pharming Group Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.3.5 CSL Limited Recent Developments
5.4 CSL Limited
5.4.1 CSL Limited Profile
5.4.2 CSL Limited Main Business
5.4.3 CSL Limited Hereditary Angioedema Therapeutic Products, Services and Solutions
5.4.4 CSL Limited Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.4.5 CSL Limited Recent Developments
5.5 Shire
5.5.1 Shire Profile
5.5.2 Shire Main Business
5.5.3 Shire Hereditary Angioedema Therapeutic Products, Services and Solutions
5.5.4 Shire Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.5.5 Shire Recent Developments
5.6 Attune Pharma
5.6.1 Attune Pharma Profile
5.6.2 Attune Pharma Main Business
5.6.3 Attune Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
5.6.4 Attune Pharma Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.6.5 Attune Pharma Recent Developments
5.7 Adverum Biotechnologies
5.7.1 Adverum Biotechnologies Profile
5.7.2 Adverum Biotechnologies Main Business
5.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Products, Services and Solutions
5.7.4 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.7.5 Adverum Biotechnologies Recent Developments
5.8 KalVista Pharma
5.8.1 KalVista Pharma Profile
5.8.2 KalVista Pharma Main Business
5.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
5.8.4 KalVista Pharma Hereditary Angioedema Therapeutic Revenue (US$ Million) & (2024-2024)
5.8.5 KalVista Pharma Recent Developments
6 North America
6.1 North America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hereditary Angioedema Therapeutic Market Dynamics
11.1 Hereditary Angioedema Therapeutic Industry Trends
11.2 Hereditary Angioedema Therapeutic Market Drivers
11.3 Hereditary Angioedema Therapeutic Market Challenges
11.4 Hereditary Angioedema Therapeutic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Hereditary Angioedema Therapeutic Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Hereditary Angioedema Therapeutic Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Hereditary Angioedema Therapeutic Market Size Share by Region (2024-2024)
Table 4. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Hereditary Angioedema Therapeutic Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Hereditary Angioedema Therapeutic Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Hereditary Angioedema Therapeutic Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2024)
Table 9. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Table 11. North America Hereditary Angioedema Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Hereditary Angioedema Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Hereditary Angioedema Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Hereditary Angioedema Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Hereditary Angioedema Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Hereditary Angioedema Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Hereditary Angioedema Therapeutic Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Hereditary Angioedema Therapeutic Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2024)
Table 24. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Table 26. North America Hereditary Angioedema Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Hereditary Angioedema Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Hereditary Angioedema Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Hereditary Angioedema Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Hereditary Angioedema Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Hereditary Angioedema Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Hereditary Angioedema Therapeutic Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2022)
Table 39. Date of Key Players Enter into Hereditary Angioedema Therapeutic Market
Table 40. Global Hereditary Angioedema Therapeutic Key Players Headquarters and Area Served
Table 41. Hereditary Angioedema Therapeutic Product Solution and Service
Table 42. Global Hereditary Angioedema Therapeutic Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. BioCryst Pharma Basic Information List
Table 45. BioCryst Pharma Description and Business Overview
Table 46. BioCryst Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 47. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of BioCryst Pharma (2024-2024)
Table 48. BioCryst Pharma Recent Developments
Table 49. Ionis Pharma Basic Information List
Table 50. Ionis Pharma Description and Business Overview
Table 51. Ionis Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 52. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of Ionis Pharma (2024-2024)
Table 53. Ionis Pharma Recent Developments
Table 54. Pharming Group Basic Information List
Table 55. Pharming Group Description and Business Overview
Table 56. Pharming Group Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 57. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of Pharming Group (2024-2024)
Table 58. Pharming Group Recent Developments
Table 59. CSL Limited Basic Information List
Table 60. CSL Limited Description and Business Overview
Table 61. CSL Limited Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 62. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of CSL Limited (2024-2024)
Table 63. CSL Limited Recent Developments
Table 64. Shire Basic Information List
Table 65. Shire Description and Business Overview
Table 66. Shire Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 67. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of Shire (2024-2024)
Table 68. Shire Recent Developments
Table 69. Attune Pharma Basic Information List
Table 70. Attune Pharma Description and Business Overview
Table 71. Attune Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 72. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of Attune Pharma (2024-2024)
Table 73. Attune Pharma Recent Developments
Table 74. Adverum Biotechnologies Basic Information List
Table 75. Adverum Biotechnologies Description and Business Overview
Table 76. Adverum Biotechnologies Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 77. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of Adverum Biotechnologies (2024-2024)
Table 78. Adverum Biotechnologies Recent Developments
Table 79. KalVista Pharma Basic Information List
Table 80. KalVista Pharma Description and Business Overview
Table 81. KalVista Pharma Hereditary Angioedema Therapeutic Products, Services and Solutions
Table 82. Revenue (US$ Million) in Hereditary Angioedema Therapeutic Business of KalVista Pharma (2024-2024)
Table 83. KalVista Pharma Recent Developments
Table 84. North America Hereditary Angioedema Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 85. North America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 86. Europe Hereditary Angioedema Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 87. Europe Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 88. Asia-Pacific Hereditary Angioedema Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 89. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2024-2024)
Table 92. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2024-2034)
Table 93. Latin America Hereditary Angioedema Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 94. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 95. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 96. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 97. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2024-2024) & (US$ Million)
Table 98. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2024-2034) & (US$ Million)
Table 99. Hereditary Angioedema Therapeutic Market Trends
Table 100. Hereditary Angioedema Therapeutic Market Drivers
Table 101. Hereditary Angioedema Therapeutic Market Challenges
Table 102. Hereditary Angioedema Therapeutic Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Angioedema Therapeutic Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Hereditary Angioedema Therapeutic Market Share by Regions: 2022 VS 2034
Figure 4. Global Hereditary Angioedema Therapeutic Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Hereditary Angioedema Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Hereditary Angioedema Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Hereditary Angioedema Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Hereditary Angioedema Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Intravenous
Figure 11. Global Intravenous Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Subcutaneous
Figure 13. Global Subcutaneous Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Oral
Figure 15. Global Oral Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Hereditary Angioedema Therapeutic Market Size Share by Type: 2022 & 2034
Figure 17. North America Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Figure 18. Europe Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Type (2024-2034)
Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Clinics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Hereditary Angioedema Therapeutic Market Size Share by Application: 2022 & 2034
Figure 26. North America Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Figure 27. Europe Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Application (2024-2034)
Figure 31. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Hereditary Angioedema Therapeutic Market Share in 2022
Figure 33. North America Hereditary Angioedema Therapeutic Market Share by Country (2024-2034)
Figure 34. U.S. Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 37. France Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2024-2034)
Figure 43. China Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 47. India Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Hereditary Angioedema Therapeutic Market Share by Country (2024-2034)
Figure 50. Mexico Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Country (2024-2034)
Figure 53. Turkey Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Hereditary Angioedema Therapeutic Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries